TUDOR INVESTMENT CORP ET AL - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 209 filers reported holding PTC THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$433,000
-35.9%
8,626
-48.9%
0.01%
-50.0%
Q2 2022$676,000
+31.0%
16,883
+22.0%
0.02%
+50.0%
Q1 2022$516,000
+27.4%
13,842
+36.1%
0.01%
+71.4%
Q4 2021$405,000
-90.5%
10,173
-91.1%
0.01%
-89.9%
Q3 2021$4,276,000
+12.1%
114,907
+27.3%
0.07%
-4.2%
Q2 2021$3,814,000
+116.8%
90,241
+142.9%
0.07%
+105.7%
Q1 2021$1,759,000
+48.2%
37,154
+91.0%
0.04%
+2.9%
Q4 2020$1,187,000
+336.4%
19,457
+142.1%
0.03%
+277.8%
Q3 2019$272,000
-31.8%
8,037
-24.3%
0.01%
-47.1%
Q1 2019$399,000
-39.9%
10,612
-45.2%
0.02%
+30.8%
Q4 2018$664,000
+28.4%
19,350
+75.9%
0.01%0.0%
Q3 2018$517,000
+14.6%
10,998
-59.3%
0.01%
+18.2%
Q4 2017$451,000
+16.8%
27,031
+40.3%
0.01%
+10.0%
Q3 2017$386,000
-5.9%
19,270
-53.8%
0.01%
-23.1%
Q1 2017$410,000
+454.1%
41,670
+296.9%
0.01%
+550.0%
Q2 2016$74,000
-86.2%
10,500
-87.4%
0.00%
-85.7%
Q1 2016$537,000
+113.9%
83,427
+787.5%
0.01%
+75.0%
Q3 2015$251,000
-46.8%
9,400
-4.1%
0.01%
-42.9%
Q2 2015$472,000
+133.7%
9,800
+195.7%
0.01%
+133.3%
Q1 2015$202,000
-56.1%
3,314
-62.7%
0.01%
-62.5%
Q4 2014$460,000
+122.2%
8,877
+88.4%
0.02%
+128.6%
Q3 2014$207,0004,7110.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,155,000$101,285,00011.24%
RTW INVESTMENTS, LP 3,275,591$153,953,0009.22%
Asymmetry Capital Management, L.P. 173,010$8,131,0007.51%
GREAT POINT PARTNERS LLC 717,458$33,721,0005.26%
Ghost Tree Capital, LLC 500,000$23,500,0005.00%
MAK CAPITAL ONE LLC 221,723$10,421,0003.41%
Opaleye Management Inc. 180,000$8,460,0002.15%
Avoro Capital Advisors LLC 684,000$32,148,0001.48%
SCOPIA CAPITAL MANAGEMENT LP 1,616,998$75,999,0001.46%
SPHERA FUNDS MANAGEMENT LTD. 210,000$9,870,0001.13%
View complete list of PTC THERAPEUTICS INC shareholders